Cost-utility Analysis of the Follow-up of Exclusive Telemedicine Pacemakers, Compared to Conventional Pacemakers

NCT04148703 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 620

Last updated 2023-06-06

No results posted yet for this study

Summary

TELEPACE is an economic evaluation that aims to determine the probability at which Home Monitoring without physical examinations, could be cost effective, compared to the conventional treatment by face to face consultations. Patient will be randomized in a control group followed according to the current guidelines and and active group exclusively followed by remote monitoring. The study will end after a 4 year follow-up.

Conditions

  • Single or Dual Chamber Pacemaker Implantation
  • Home Monitoring Follow-up

Interventions

OTHER

Follow up post Pacemaker implantation in office

All patients will be implanted with a single or dual chamber pacemaker according the implantation guidelines and will be followed by in-office follow-up

OTHER

Follow up post Pacemaker implantation by home monitoring

All patients will be implanted with a single or dual chamber pacemaker according the implantation guidelines and will be followed by home monitoring

Sponsors & Collaborators

  • Tours University Hospital

    collaborator UNKNOWN
  • University Hospital, Marseille

    collaborator OTHER
  • Rennes University Hospital

    collaborator OTHER
  • University Hospital, Toulouse

    collaborator OTHER
  • University Hospital, Clermont-Ferrand

    collaborator OTHER
  • Angers University Hospital

    collaborator UNKNOWN
  • Lille University Hospital

    collaborator UNKNOWN
  • University Hospital, Strasbourg, France

    collaborator OTHER
  • University Hospital, Rouen

    collaborator OTHER
  • Montpellier University Hospital

    collaborator UNKNOWN
  • University Hospital, Brest

    collaborator OTHER
  • Pau University Hospital

    collaborator UNKNOWN
  • Nantes University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-04
Primary Completion
2025-05-05
Completion
2025-05-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04148703 on ClinicalTrials.gov